Commonwealth Pain Specialists offers treatment with CTT's Calmare Pain Therapy device

Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that Commonwealth Pain Specialists, the premier pain management center in Richmond and Central Virginia, is treating patients suffering from chronic, intense neuropathic pain using CTT's Calmare^® Pain Therapy medical device.

"We are excited to have John Barsanti, M.D. and Stephen Long, M.D., and their team treating patients with our Calmare device," said John B. Nano, CTT's Chairman, President and CEO. "We are all committed to improving patients' quality of life. From the growing body of evidence-based patient outcomes, we know that our Calmare device successfully treats chronic neuropathic and oncologic pain resulting from cancer, phantom limb syndrome, failed back surgery, sciatica, spinal stenosis, shingles and other maladies." 

"We are pleased to offer this non-invasive solution for our patients who suffer from severe and intractable pain," said Dr. John Barsanti. "We are already seeing the benefit to patients from using the Calmare Pain Therapy and are excited at the prospect of helping our patients avoid the negative side effects of narcotic painkillers and improve the quality of their lives."

The non-invasive Calmare Pain Therapy device uses the biophysical "Scrambler Therapy" technology, which was developed in Italy by CTT's client, Professor Giuseppe Marineo. CTT's partner, GEOMC Co. Ltd. of Seoul, Korea is manufacturing the Calmare device, which has U.S. FDA clearance and European Union CE Mark clearance for sales.